CDK Global (CDK) Tops Q4 EPS by 5c

CDK Global (NASDAQ: CDK) reported Q4 EPS of $0.37, $0.05 better than the analyst estimate of $0.32. Revenue for the quarter came in at $521.2 million versus the consensus estimate of $520.7 million.

For earnings history and earnings-related data on CDK Global (CDK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Yum! Brands (YUM) PT Lowered to $180 at Argus